SciELO - Scientific Electronic Library Online

 
vol.22 issue2Prevalence of rheumatic disease in a cohort of patients with human immunodeficiency virus infectionComputational model for the identification of endophenotypes and classification of rheumatoid arthritis patients from genetic, serological, and clinical data using computational intelligence techniques author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Reumatología

Print version ISSN 0121-8123

Abstract

PARRA IZQUIERDO, Viviana; MONTENEGRO, Edison  and  LONDONO, John. Cardiovascular manifestations in patients with systemic lupus erythematosus during a one-year period in an institution in Cundinamarca, Colombia. Rev.Colomb.Reumatol. [online]. 2015, vol.22, n.2, pp.84-89. ISSN 0121-8123.  https://doi.org/10.10167j.rcreu.2015.05.001.

Introduction: Cardiovascular disease is a poorly recognized problem in systemic lupus erythematosus (SLE) patients, who may have their disease activity associated with cardiac disease at the time of diagnosis or at a later stage of the course of disease. Manifestations are variable, as all structures of the heart can be affected, and can cause significant morbidity and mortality. Objective: The presentation may vary from subclinical form to advanced stages, which require aggressive immunosuppressive therapy. A description is presented of the frequency of these manifestations in patients with systemic lupus erythematosus attending a reference institution of Cundinamarca, Colombia. Methods: A retrospective study was conducted with the recording of clinical aspects, laboratory tests, and cardiovascular manifestations over a period of one year. Results: The study included a total of 45 patients with confirmed diagnosis of SLE, with a mean age of 35 years. Deterioration in functional class and dyspnea occurred more frequently. A positive anti-DNA was more frequent in patients with dyspnea (p=.037) and impaired functional class (p=.023). The lupus anticoagulant is also present in patients with deep venous thrombosis (60 vs. 15%; p=.018), and in patients with heart failure (66 vs. 16%: p=.036). Conclusion: Cardiovascular symptoms are present in a high percentage of patients with SLE, thus these should be questioned to in order to detect them earlier and avoid cardiovascular complications. It is suggested that some autoantibodies, as anti-DNA, lupus anticoagulant, low plasma complement, and anti-C1q, could also be useful for detecting new cardiovascular events in patients with SLE.

Keywords : Lupus erythematosus systemic; Cardiovascular diseases; cardiovascular system.

        · abstract in Spanish     · text in English     · English ( pdf )